IMAAVY: Affected lots may contain glass particles
Brand(s)
Last updated
Summary
Product
IMAAVY Solution
Issue
Health products - Product quality
What to do
Consult your healthcare provider for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Janssen Inc |
IMAAVY |
DIN 02563509 |
Solution |
300 mg/ 1.62 mL |
JNYJ1202, JNYJ1206 |
Issue
| Affected lots may contain glass particles. |
What you should do
- Verify if your product is affected.
- Consult your healthcare provider for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Biologic or vaccine
Companies
|
Janssen Inc 19 Green Belt Drive |
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-82660
Get notified
Receive emails about new and updated recall and safety alerts.